Modulight Biotherapeutics

About Modulight Biotherapeutics

Modulight Biotherapeutics is pioneering a new era of medicine by harnessing the power of light to develop a precision neuromodulation platform using optogenetics. Their mission is to treat severe neurological disorders with fast-acting, precise solutions that provide relief without side effects, helping patients regain function and comfort in critical moments such as stopping seizures, calming tremors, or easing persistent pain.

Products & Services

Precision Neuromodulation Platform:A platform using optogenetics to treat severe neurological disorders with precision and minimal side effects.

Trigeminal Neuropathic Pain Therapy:A light therapy targeting debilitating neuropathic pain in the trigeminal nerve, selected as the first indication for clinical studies.

Specialties

Optogenetics Precision Neuromodulation Neurological Disorder Treatment Light Therapy

Funding History

Debug: View Raw Funding Data

#	Type	Amount Fields	Date Fields	Investors
1	RT: Seed T: - FT: Seed	A: 12200000 MR: - FA: $12.2 million FAN: 12200000	D: 2025-11-12 FD: 2025-11-12	9 investors

Seed Latest

2025-11-12

$12.2M

9 investors (Pro only)

Growth Metrics

+45%

Employee Growth

YoY

3.2x

Funding Growth

Last Round

12

Markets

Operating

10K+

Customers

Active

View 3 more growth metrics with Pro

Unlock All Metrics

Mock Up

Team & Leadership

O

Ofir Levi, PhD

Co-Founder and Chairman of the Board

LinkedIn (Pro only)

Y

Yotam Eldar

Co-Founder and Chief Executive Officer

LinkedIn (Pro only)

O

Ofer Yizhar

Principal Investigator

Y

Yoav Kfir

VP of Research and Development

J

Jennifer Daily

VP of Preclinical development

S

Sasha Devore

Director of Scientific Communications and Engagement

View 21 more team members with Pro

Unlock Full Team Directory

Recent News